279 related articles for article (PubMed ID: 25239564)
1. Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.
Xu W; Ge Y; Liu Z; Gong R
Am J Pathol; 2014 Oct; 184(10):2742-56. PubMed ID: 25239564
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion.
Xu W; Ge Y; Liu Z; Gong R
J Biol Chem; 2015 Jan; 290(3):1348-63. PubMed ID: 25468908
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.
Wang Z; Bao H; Ge Y; Zhuang S; Peng A; Gong R
Br J Pharmacol; 2015 Feb; 172(3):895-909. PubMed ID: 25262943
[TBL] [Abstract][Full Text] [Related]
4. Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.
Bao H; Ge Y; Peng A; Gong R
Kidney Int; 2015 Jun; 87(6):1176-90. PubMed ID: 25629551
[TBL] [Abstract][Full Text] [Related]
5. The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.
Li C; Ge Y; Dworkin L; Peng A; Gong R
J Pathol; 2016 May; 239(1):23-35. PubMed ID: 26876299
[TBL] [Abstract][Full Text] [Related]
6. Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.
Zhou S; Wang P; Qiao Y; Ge Y; Wang Y; Quan S; Yao R; Zhuang S; Wang LJ; Du Y; Liu Z; Gong R
J Am Soc Nephrol; 2016 Aug; 27(8):2289-308. PubMed ID: 26647425
[TBL] [Abstract][Full Text] [Related]
7. Eucalyptol Ameliorates Dysfunction of Actin Cytoskeleton Formation and Focal Adhesion Assembly in Glucose-Loaded Podocytes and Diabetic Kidney.
Kim DY; Kang MK; Kim YH; Lee EJ; Oh H; Kim SI; Oh SY; Kang YH
Mol Nutr Food Res; 2019 Nov; 63(22):e1900489. PubMed ID: 31483951
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.
Crean JK; Furlong F; Finlay D; Mitchell D; Murphy M; Conway B; Brady HR; Godson C; Martin F
FASEB J; 2004 Oct; 18(13):1541-3. PubMed ID: 15319369
[TBL] [Abstract][Full Text] [Related]
9. IL-6 increases podocyte motility via MLC-mediated focal adhesion impairment and cytoskeleton disassembly.
He FF; Bao D; Su H; Wang YM; Lei CT; Zhang CY; Ye C; Tang H; Wan C; You CQ; Zhang J; Xiong J; Zhang C
J Cell Physiol; 2018 Sep; 233(9):7173-7181. PubMed ID: 29574897
[TBL] [Abstract][Full Text] [Related]
10. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
11. The redox-sensitive GSK3β is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease.
Chen M; Fang Y; Ge Y; Qiu S; Dworkin L; Gong R
Redox Biol; 2024 Jun; 72():103127. PubMed ID: 38527400
[TBL] [Abstract][Full Text] [Related]
12. HGF alleviates high glucose-induced injury in podocytes by GSK3β inhibition and autophagy restoration.
Zhang C; Hou B; Yu S; Chen Q; Zhang N; Li H
Biochim Biophys Acta; 2016 Nov; 1863(11):2690-2699. PubMed ID: 27526674
[TBL] [Abstract][Full Text] [Related]
13. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
14. Valproate hampers podocyte acquisition of immune phenotypes via intercepting the GSK3β facilitated NFkB activation.
Wang P; Zhou S; Ge Y; Lu M; Liu Z; Gong R
Oncotarget; 2017 Oct; 8(51):88332-88344. PubMed ID: 29179438
[TBL] [Abstract][Full Text] [Related]
15. Delayed administration of a single dose of lithium promotes recovery from AKI.
Bao H; Ge Y; Wang Z; Zhuang S; Dworkin L; Peng A; Gong R
J Am Soc Nephrol; 2014 Mar; 25(3):488-500. PubMed ID: 24408869
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2.
Yoshino Y; Suzuki M; Takahashi H; Ishioka C
Biochem Biophys Res Commun; 2015 Aug; 464(1):275-80. PubMed ID: 26116771
[TBL] [Abstract][Full Text] [Related]
17. Age-related GSK3β overexpression drives podocyte senescence and glomerular aging.
Fang Y; Chen B; Liu Z; Gong AY; Gunning WT; Ge Y; Malhotra D; Gohara AF; Dworkin LD; Gong R
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166234
[TBL] [Abstract][Full Text] [Related]
18. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
Paeng J; Chang JH; Lee SH; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Yoo TH; Kang SW
Apoptosis; 2014 Dec; 19(12):1678-90. PubMed ID: 25284613
[TBL] [Abstract][Full Text] [Related]
19. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.
Li C; Ge Y; Peng A; Gong R
Oncotarget; 2015 Nov; 6(37):39493-506. PubMed ID: 26567873
[TBL] [Abstract][Full Text] [Related]
20. Role of the Ste20-like kinase SLK in podocyte adhesion.
Cybulsky AV; Papillon J; Bryan C; Navarro-Betancourt JR; Sabourin LA
Physiol Rep; 2024 Jan; 12(1):e15897. PubMed ID: 38163671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
